INTRODUCTION The pharmaceutical industry is praised as one of the leading industrial sectors. The fruits of its extensive research and development are traded worldwide and have improved the length and quality of life of countless individuals. At the same time‚ however‚ the industry is criticized for its marketing and pricing practices—and even for its research and development priorities. Industry’s consistently high profits and large expenditures on research and development as well as on marketing
Premium Cost Supply and demand Economics
THE BALANCED SCORECARD IN AN INDONESIAN PHARMACEUTICAL COMPANY A CASE STUDY IN PT. DEXA MEDICA 1. INTRODUCTION 1.1. Background of the Study In modern competitive global economy‚ it is more important than ever to understand the process of value creation in the organization. The need to manage with a high level of customer focus‚ a clearer understanding of core business processes‚ the necessity of motivation and commitment of employees‚ the need for change on a continuous basis‚ and effective
Premium Strategic management Balanced scorecard
Pharma billionaire arrested for bribing doctors to prescribe opioid painkillers (-- removed HTML --) The pharmaceutical industry needs people to keep getting sick and they need new diseases to infect the human population. They need these things because they need to keep making money. The pharmaceutical industry is worth billions of dollars and no one wants to lose any money. That’s why‚ even though there’s an opioid crisis that kills tens of thousands of people a year and was originally declared
Premium
EXTERNAL ENVIRONMENT (General Environment) A company like Teva Pharmaceuticals is subject to all of the factors of the external environment given the nature of its business and global expansion. Pharmaceuticals is an industry where high profits can be achieved‚ but it is also an extremely challenging business when one considers all of the political/legal aspects involving government regulation and patents. Every country has strict regulation and testing requirements for drugs that affect companies
Premium Generic drug Food and Drug Administration
Harvard Case Study Kramer Pharmaceuticals‚ Inc. By: Derek A. Newton Management “Honors” 3300 Section EMWA Professor Walsh Kris Bonilla Daniella DiBenedetto Fact Sheet: * Company name: Kramer Pharmaceuticals‚ Inc. * Major manufacturer of prescription drugs. * Sales force of over 500 detailers * Detailers responsible for about 200 accounts * 35 District managers * Detailer: Bob Marsh * Worked for Kramer Pharmaceuticals for 12 years * Territory
Premium Management Sales Leadership
Knowledge Management in the Pharmaceutical Industry Introduction The study of Knowledge Management is a process that has been researched for centuries by western philosophers and traditional theorists‚ however it is only until recently that knowledge management has been the main focus for many organisations. Many have said that it was the publishing of Karl Wiig’s‚ “knowledge management foundations” (1993)‚ that sparked the huge interest in knowledge management and nearly two decades on KM is
Premium Knowledge management Pharmacy
CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Report On CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Course Code: BUS-498 Submitted to: Md. Jahirul Islam Lecturer‚ ASAUB Submitted by: Farhana Bhuiyan ID# 073-12-0020 BBA 3rd Batch‚ ASAUB [pic] ASA UNIVERSITY BANGLADESH December‚ 2011 Declaration of originality
Premium Corporate social responsibility
candidates that can be further developed. Pharmaceutical companies often have relevant compounds that have not been assessed for their potential to treat colorectal cancer. The overall objective for this company‚ Arias Pharmaceuticals‚ is to help and support the discovery of new drug leads for colorectal cancer through networks and partnerships between pharmaceutical companies as well as academia. Specifically‚ the
Premium Colorectal cancer Cancer Drug discovery
Pharmaceutical Society of Great Britain v Boots [1953] 1 QB 401 Court of Appeal Boots introduced the then new self service system into their shops whereby customers would pick up goods from the shelf put them in their basket and then take them to the cash till to pay. The Pharmaceutical Society of Great Britain brought an action to determine the legality of the system with regard to the sale of pharmaceutical products which were required by law to be sold in the presence of a pharmacist. The court
Premium Contract Pharmacist Appeal
“At Acadia‚ our mission is to improve the lives of patients by developing innovative treatments that address unmet medical needs in neurological and related central nervous and related central nervous system disorders.” Acadia Pharmaceuticals mission statement. The heart of the company’s strategy. Upon analysis of Acadia’s website‚ it can be assumed they are adhering to their mission statement due to several items on their about us page and elsewhere on the site. On Acadia’s about us page they talk
Premium Clinical trial Neurology Central nervous system